Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma (Companion Faculty Lecture) episode artwork

EPISODE · Feb 6, 2023 · 34 MIN

Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma (Companion Faculty Lecture)

from Research To Practice | Oncology Videos · host Dr. Neil Love

Featuring a slide presentation and related discussion from Dr Gilles Salles, including the following topics: Recent data with polatuzumab vedotin/bendamustine/rituximab for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) (0:00) Available data from trials evaluating tafasitamab/lenalidomide, loncastuximab tesirine and selinexor for DLBCL (12:57) Current and future roles of chimeric antigen receptor (CAR) T-cell therapy, bispecific antibodies and combination therapies for DLBCL (21:43) CME information and select publications

Episode metadata supplied by the publisher feed · Published Feb 6, 2023

Embed this episode

NOW PLAYING

Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma (Companion Faculty Lecture)

0:00 34:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Research To Practice | Oncology Videos?

This episode is 34 minutes long.

When was this Research To Practice | Oncology Videos episode published?

This episode was published on February 6, 2023.

Can I download this Research To Practice | Oncology Videos episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!